Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour

International Journal of Neuropsychopharmacology

Volumn 14, Issue 7, 2011, Pages 927-940

  Orejarena, María Juliana ^a   Lanfumey, Laurence ^c   Maldonado, Rafael ^a   Robledo, Patricia ^a,b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b Barcelona Biomedical Research Park   (Spain)

^c INSERM   (France)

Author keywords

Dopamine; food intake; locomotion; microdialysis; SR46349B

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; EPLIVANSERIN; NORADRENALIN; SEROTONIN; SEROTONIN 2A RECEPTOR; FLUOROBENZENE; PHENOL DERIVATIVE; SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG DOSE COMPARISON; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; HISTOPATHOLOGY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; NORADRENALIN BRAIN LEVEL; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; REINFORCEMENT; SEROTONIN BRAIN LEVEL; WILD TYPE; ADDICTION; ANIMAL; ASSOCIATION; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENETICS; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ADDICTIVE; CUES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; FEMALE; FLUOROBENZENES; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NOREPINEPHRINE; NUCLEUS ACCUMBENS; PHENOLS; PREFRONTAL CORTEX; RECEPTOR, SEROTONIN, 5-HT2A; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SEROTONIN; SEROTONIN 5-HT2 RECEPTOR AGONISTS; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS;

EID: 80052969247     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710001215     Document Type: Article

References (65)

1. Andree B, Nyberg S, Ito H, Ginovart N, et al. (1998). Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain. Journal of Clinical Psychopharmacology 18, 317-323. (Pubitemid 28353875)
2. Auclair A, Blanc G, Glowinski J, Tassin JP (2004a). Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors. Journal of Neurochemistry 91, 318-326. (Pubitemid 39363431)
3. Auclair A, Drouin C, Cotecchia S, Glowinski J, et al. (2004b). 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. European Journal of Neuroscience 20, 3073-3084. (Pubitemid 40007302)
4. Ball KT, Rebec GV (2005). Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylene-dioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats. Psycho-pharmacology (Berlin) 181, 676-687. (Pubitemid 41400753)
5. Ball KT, Walsh KM, Rebec GV (2007). Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues. Pharmacology Biochemistry and Behavior 87, 420-425. (Pubitemid 47238400)
6. Bankson MG, Cunningham KA (2002). Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors. Neuropsychopharmacology 26, 40-52. (Pubitemid 34075275)
7. Bilsky EJ, Montegut MJ, Nichols ML, Reid LD (1998). CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. Pharmacology Biochemistry and Behavior 59, 215-220. (Pubitemid 28053701)
8. Bortolozzi A, az-Mataix L, Scorza MC, Celada P, et al. (2005). The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. Journal of Neurochemistry 95, 1597-1607. (Pubitemid 41804057)
9. Bradberry CW, Rubino SR (2004). Phasic alterations in dopamine and serotonin release in striatum and prefrontal cortex in response to cocaine predictive cues in behaving rhesus macaques. Neuropsychopharmacology 29, 676-685. (Pubitemid 38402475)
10. Carrasco GA, Battaglia G (2007). Withdrawal from a single exposure to cocaine increases 5-HT2A receptor and G protein function. Neuroreport 18, 51-55. (Pubitemid 46183389)
11. Carrasco GA, Van de Kar LD, Jia C, Xu H, et al. (2007). Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo. Journal of Pharmacology and Experimental Therapeutics 320, 1078-1086. (Pubitemid 46294064)
12. Ciccocioppo R, Sanna PP, Weiss F (2001). Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proceedings of the National Academy of Sciences USA 98, 1976-1981. (Pubitemid 32165608)
13. Cottler LB, Womack SB, Compton WM, Ben Abdallah A (2001). Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Human Psychopharmacology 16, 599-606. (Pubitemid 34036940)
14. Daniela E, Brennan K, Gittings D, Hely L, et al. (2004). Effect of SCH 23390 on (+/-)-3,4-methylenedioxy-methamphetamine hyperactivity and self-administration in rats. Pharmacology Biochemistry and Behavior 77, 745-750. (Pubitemid 38510285)
15. De Deurwaerdère P, Spampinato U (1999). Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. Journal of Neurochemistry 73, 1033-1042. (Pubitemid 29395459)
16. De Deurwaerdère P, Stinus L, Spampinato U (1998). Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors. Journal of Neuroscience 18, 6528-6538. (Pubitemid 28373254)
17. Depoortère R, Auclair AL, Bardin L, Colpaert FC, et al. (2010). F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists. European Neuropsychopharmacology 20, 641-654.
18. Doly S, Bertran-Gonzalez J, Callebert J, Bruneau A, et al. (2009). Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice. PLOS One 4, e7952.
19. Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, et al. (2003). Pharmacological characterization of the effects of 3,4- methylenedioxymethamphetamine ('ecstasy') and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology (Berlin) 166, 202-211. (Pubitemid 36384765)
20. Fantegrossi WE, Ullrich T, Rice KC, Woods JH, et al. (2002). 3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology (Berlin) 161, 356-364. (Pubitemid 34595786)
21. Filip M, Bubar MJ, Cunningham KA (2006). Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats. Psychopharmacology (Berlin) 183, 482-489. (Pubitemid 41721150)
22. Fiorica-Howells E, Hen R, Gingrich J, Li Z, et al. (2002). 5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice. American Journal of Physiology-Gastrointestinal and Liver 282, G877-G893. (Pubitemid 34651633)
23. Fletcher PJ, Grottick AJ, Higgins GA (2002a). Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27, 576-586.
24. Fletcher PJ, Korth KM, Robinson SR, Baker GB (2002b). Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology (Berlin) 162, 282-291. (Pubitemid 34762287)
25. Gobert A, Millan MJ (1999). Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38, 315-317. (Pubitemid 29073553)
26. Gonzalez-Maeso J, Weisstaub NV, Zhou M, Chan P, et al. (2007). Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53, 439-452. (Pubitemid 46161267)
27. Gonzalez-Maeso J, Yuen T, Ebersole BJ, Wurmbach E, et al. (2003). Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. Journal of Neuroscience 23, 8836-8843. (Pubitemid 37210895)
28. Green AR, Mechan AO, Elliott JM, O'Shea E, et al. (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacology Reviews 55, 463-508. (Pubitemid 37013213)
29. Han DD, Gu HH (2006). Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacology 6, 6.
30. Herin DV, Liu S, Ullrich T, Rice KC, et al. (2005). Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylene-dioxymethamphetamine. Psychopharmacology (Berlin) 178, 505-513. (Pubitemid 40486991)
31. Hyman SE, Malenka RC, Nestler EJ (2006). Neural mechanisms of addiction: the role of reward-related learning and memory. Annual Review of Neuroscience 29, 565-598. (Pubitemid 44476856)
32. Ito H, Nyberg S, Halldin C, Lundkvist C, et al. (1998). PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. Journal of Nuclear Medicine 39, 208-214. (Pubitemid 28063197)
33. Jiang X, Xing G, Yang C, Verma A, et al. (2009). Stress impairs 5-HT2A receptor-mediated serotonergic facilitation of GABA release in juvenile rat basolateral amygdala. Neuropsychopharmacology 34, 410-423.
34. Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, et al. (1996). Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15, 116-124. (Pubitemid 26255158)
35. Leysen JE (2004). 5-HT2 receptors. Current Drug Targets. CNS Neurological Disorders 3, 11-26.
36. Leung KS, Cottler LB (2008). Ecstasy and other club drugs: a review of recent epidemiologic studies. Current Opinion in Psychiatry 21, 234-241. (Pubitemid 351489341)
37. Liechti ME, Saur MR, Gamma A, Hell D, et al. (2000). Psychological and physiological effects of MDMA ('Ecstasy') after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology 23, 396-404.
38. Lopez-Gimenez JF, Mengod G, Palacios JM, Vilaro MT (1997). Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907. Naunyn-Schmiedeberg's Archives of Pharmacology 356, 446-454. (Pubitemid 27402083)
39. McDonald AJ, Mascagni F (2007). Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala. Neuroscience 146, 306-320. (Pubitemid 46661886)
40. Moser PC, Moran PM, Frank RA, Kehne JH (1996). Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist. Behavioural Brain Research 73, 163-167.
41. Navailles S, Moison D, Cunningham KA, Spampinato U (2008). Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine. Neuropsychopharmacology 33, 237-246. (Pubitemid 350243355)
42. Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, et al. (2009). Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behavioral Neuroscience 123, 382-396.
43. Nichols DE, Oberlender R (1989). Structure-activity relationships of MDMA-like substances. NIDA Research Monographs 94, 1-29.
44. Parrott AC (2001). Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Human Psychopharmacology 16, 557-577. (Pubitemid 34040989)
45. Parrott AC, Sisk E, Turner JJ (2000). Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. Drug and Alcohol Dependence 60, 105-110. (Pubitemid 30255991)
46. Peddie CJ, Davies HA, Colyer FM, Stewart MG, et al. (2008). Dendritic colocalisation of serotonin1B receptors and the glutamate NMDA receptor subunit NR1 within the hippocampal dentate gyrus: an ultrastructural study. Journal of Chemical Neuroanatomy 36, 17-26.
47. Pehek EA, Nocjar C, Roth BL, Byrd TA, et al. (2006). Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress-and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 31, 265-277. (Pubitemid 43113392)
48. Popa D, Lena C, Fabre V, Prenat C, et al. (2005). Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knockout mice lacking 5-HT2A receptors. Journal of Neuroscience 25, 11231-11238. (Pubitemid 43083697)
49. Porras G, Di Matteo V, Fracasso C, Lucas G, et al. (2002). 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26, 311-324. (Pubitemid 34159209)
50. Ramos M, Goni-Allo B, Aguirre N (2005). Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade. Neuropsychopharmacology 30, 2180-2191. (Pubitemid 41643969)
51. Reneman L, Endert E, de Bruin K, Lavalaye J, et al. (2002). The acute and chronic effects of MDMA ('ecstasy') on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26, 387-396. (Pubitemid 34159216)
52. Salomon L, Lanteri C, Godeheu G, Blanc G, et al. (2007). Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors. Psychopharmacology (Berlin) 194, 11-20. (Pubitemid 47282731)
53. Scearce-Levie K, Viswanathan SS, Hen R (1999). Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor. Psychopharmacology (Berlin) 141, 154-161. (Pubitemid 29200166)
54. Schenk S, Hely L, Gittings D, Lake B, et al. (2008). Effects of priming injections of MDMA and cocaine on reinstatement of MDMA-and cocaine-seeking in rats. Drug and Alcohol Dependence 96, 249-255.
55. Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL (1992). 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. European Journal of Pharmacology 223, 65-74.
56. See RE (2005). Neural substrates of cocaine-cue associations that trigger relapse. European Journal of Pharmacology 526, 140-146. (Pubitemid 41744112)
57. Sorensen SM, Kehne JH, Fadayel GM, Humphreys, et al. (1993). Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. Journal of Pharmacology and Experimental Therapeutics 266, 684-691. (Pubitemid 23318678)
58. Stone AL, Storr CL, Anthony JC (2006). Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence. International Journal of Methods in Psychiatric Research 15, 116-130. (Pubitemid 47047003)
59. Trigo JM, Orejarena MJ, Maldonado R, Robledo P (2009). MDMA reinstates cocaine-seeking behaviour in mice. European Neuropsychopharmacology 19, 391-397.
60. Trigo JM, Renoir T, Lanfumey L, Hamon M, et al. (2007). 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biological Psychiatry 62, 669-679. (Pubitemid 47314373)
61. Van den Oever MC, Spijker S, Smit AB, de Vries TJ (2009). Prefrontal cortex plasticity mechanisms in drug seeking and relapse. Neuroscience & Biobehavioral Reviews. Published online: 22 September 2009. doi:10.1016/j. neubiorev.2009.11.016
62. Vazquez-Borsetti P, Cortes R, Artigas F (2009). Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors. Cerebral Cortex 19, 1678-1686.
63. Vollenweider FX, Liechti ME, Gamma A, Greer G, et al. (2002). Acute psychological and neurophysiological effects of MDMA in humans. Journal of Psychoactive Drugs 34, 171-184. (Pubitemid 34809986)
64. Weisstaub NV, Zhou M, Lira A, Lambe E, et al. (2006). Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313, 536-540. (Pubitemid 44148461)
65. Yan Y, Nabeshima T (2009). Mouse model of relapse to the abuse of drugs: procedural considerations and characterizations. Behavioral Brain Research 196, 1-10.